Literature DB >> 33663332

Value of contrast-enhanced ultrasonography in radiofrequency ablation of secondary hyperparathyroidism.

Xiachuan Qin1, Baofu Wang2, Boliang Li2, Changwei Lin2, Xuebin Liu1, Xisheng Xie2.   

Abstract

OBJECTIVES: The purpose of the current study was to determine the performance of contrast-enhanced ultrasound (CEUS) in the assessment of radiofrequency ablation (RFA) of hyperplastic parathyroid glands due to secondary hyperparathyroidism (SHPT).
METHODS: Thirty-two patients, each with ≥4 hyperplastic parathyroid glands due to SHPT, underwent RFA via hydro-dissection. CEUS was performed in each patient before and during RFA. The patients in whom the intact parathyroid hormone (iPTH) level did not decrease to 300 pg/ml were examined by CEUS. The iPTH, serum calcium, and serum phosphorus levels before and after RFA were compared.
RESULTS: Ablation was achieved in all patients (131 ablated glands). The volume of the glands was 479.88 ± 549.3mm3. The pre-operative and day 1 post-operative iPTH levels were 2355 ± 1062 and 292.7 ± 306.8 pg/ml, respectively. Three nodules in three patients showed little enhancement on CEUS on post-operative day 1. The iPTH level was <300 pg/mL on post-operative day 1 in 23 patients, which indicated complete ablation; follow-up evaluations were therefore performed. The pre- and post-operative iPTH levels in the 23 patients were 2113 ± 787.2 and 106.2 ± 84.62 pg/ml, respectively (p < 0.05), and the 6- and 12-month post-operative iPTH levels were 111.1 ± 56.57 and 117.6 ± 97.08 pg/ml, respectively (p > 0.05).
CONCLUSIONS: CEUS-guided RFA is effective and feasible for the treatment of ≥4 hyperplastic parathyroid glands. CEUS was shown to assist the surgeon before, during, and after RFA. CEUS on post-operative day 2, but not immediately post-operatively, was shown to accurately reflect gland perfusion.

Entities:  

Keywords:  Hyperplastic parathyroid gland; chronic kidney disease; contrast-enhanced ultrasound; radiofrequency ablation; secondary hyperparathyroidism

Mesh:

Substances:

Year:  2021        PMID: 33663332      PMCID: PMC7939554          DOI: 10.1080/0886022X.2021.1889601

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  21 in total

1.  Intraoperative decay profile of intact (1-84) parathyroid hormone in surgery for renal hyperparathyroidism--a consecutive series of 80 patients.

Authors:  J Lokey; F Pattou; A Mondragon-Sanchez; M Minuto; B Mullineris; F Wambergue; P Foissac-Geroux; C Noel; H L de Sagazan; P VanHille; C A Proye
Journal:  Surgery       Date:  2000-12       Impact factor: 3.982

2.  Radiofrequency ablation guided by contrast-enhanced ultrasound for hepatic malignancies: preliminary results.

Authors:  Y Dong; W-P Wang; Y-H Gan; B-J Huang; H Ding
Journal:  Clin Radiol       Date:  2014-07-22       Impact factor: 2.350

3.  Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma.

Authors:  Yang Guang; Yukun Luo; Yan Zhang; Mingbo Zhang; Nan Li; Ying Zhang; Jie Tang
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-24       Impact factor: 4.553

4.  Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: First results of CEUS evaluation.

Authors:  Chong-Ke Zhao; Hui-Xiong Xu; Feng Lu; Li-Ping Sun; Ya-Ping He; Le-Hang Guo; Xiao-Long Li; Xiao-Wan Bo; Wen-Wen Yue
Journal:  Clin Hemorheol Microcirc       Date:  2017       Impact factor: 2.375

Review 5.  The surgical management of renal hyperparathyroidism.

Authors:  Catherine Madorin; Randall P Owen; William D Fraser; Phillip K Pellitteri; Brian Radbill; Alessandra Rinaldo; Raja R Seethala; Ashok R Shaha; Carl E Silver; Matthew Y Suh; Barrie Weinstein; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-20       Impact factor: 2.503

Review 6.  Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.

Authors:  John Cunningham; Francesco Locatelli; Mariano Rodriguez
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-31       Impact factor: 8.237

7.  US-guided Microwave Ablation of Hyperplastic Parathyroid Glands: Safety and Efficacy in Patients with End-Stage Renal Disease-A Pilot Study.

Authors:  Li Zhuo; Li-Li Peng; Yu-Mei Zhang; Zhi-Hong Xu; Gu-Ming Zou; Xin Wang; Wen-Ge Li; Ming-de Lu; Ming-An Yu
Journal:  Radiology       Date:  2016-08-22       Impact factor: 11.105

8.  Large carboxy-terminal parathyroid hormone (PTH) fragment with a relatively longer half-life than 1-84 PTH is secreted directly from the parathyroid gland in humans.

Authors:  Hiroyuki Yamashita; Ping Gao; Tom Cantor; Tetsuhiro Futata; Tsukasa Murakami; Shinya Uchino; Shin Watanabe; Hitoshi Kawamoto; Masafumi Fukagawa; Shiro Noguchi
Journal:  Eur J Endocrinol       Date:  2003-10       Impact factor: 6.664

Review 9.  Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations.

Authors:  Dong Gyu Na; Jeong Hyun Lee; So Lyung Jung; Ji-Hoon Kim; Jin Yong Sung; Jung Hee Shin; Eun-Kyung Kim; Joon Hyung Lee; Dong Wook Kim; Jeong Seon Park; Kyu Sun Kim; Seon Mi Baek; Younghen Lee; Semin Chong; Jung Suk Sim; Jung Yin Huh; Jae-Ik Bae; Kyung Tae Kim; Song Yee Han; Min Young Bae; Yoon Suk Kim; Jung Hwan Baek
Journal:  Korean J Radiol       Date:  2012-03-07       Impact factor: 3.500

10.  Total parathyroidectomy with trace amounts of parathyroid tissue autotransplantation as the treatment of choice for secondary hyperparathyroidism: a single-center experience.

Authors:  Qingqing He; Dayong Zhuang; Luming Zheng; Ziyi Fan; Peng Zhou; Jian Zhu; Songjian Duan; Yanning Li; Yanming Ge; Zhen Lv; Lei Cao
Journal:  BMC Surg       Date:  2014-05-05       Impact factor: 2.102

View more
  2 in total

1.  The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism.

Authors:  Xiaoer Zhang; Wenxin Xu; Tongyi Huang; Jingzhi Huang; Chunyang Zhang; Yutong Zhang; Xiaoyan Xie; Ming Xu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

2.  Evaluation of efficacy of ultrasound-guided microwave ablation in primary hyperparathyroidism.

Authors:  Mingzhu Zhang; Yuxiu Gao; Xiaojuan Zhang; Zhaoyan Ding; Xinya Wang; Wenbin Jiang; Cheng Zhao
Journal:  J Clin Ultrasound       Date:  2022-01-05       Impact factor: 0.869

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.